Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus | MicrobiomeTrials

← Back to trials

NCT04877691

Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2021-06-08Est. Completion: 2025-08-22

Enrollment target: 367 participants

Locations

Research Site, Birmingham, Alabama, United States
Research Site, Paradise Valley, Arizona, United States
Research Site, Phoenix, Arizona, United States
Research Site, El Cajon, California, United States
Research Site, Fullerton, California, United States
Research Site, Hemet, California, United States
Research Site, La Mesa, California, United States
Research Site, Los Angeles, California, United States
Research Site, Menifee, California, United States
Research Site, Upland, California, United States
Research Site, Aurora, Colorado, United States
Research Site, Brandon, Florida, United States
Research Site, Clearwater, Florida, United States
Research Site, Clearwater, Florida, United States
Research Site, Miami, Florida, United States
Research Site, Tampa, Florida, United States
Research Site, Tampa, Florida, United States
Research Site, Idaho Falls, Idaho, United States

Other microbiome trials you might be interested in

An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus ErythematosusPhase 3ENROLLING_BY_INVITATION

Systemic Lupus Erythematosus (SLE)

In this study, researchers will learn more about a study drug called litifilimab (BIIB059) in participants with systemic…

Phoenix, United StatesCompleted Mar 29, 2030

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus ErythematosusPhase 2Recruiting

Cutaneous Lupus Erythematosus (CLE)Systemic Lupus ErythematosusSLESLE (Systemic Lupus)CLE

The goal of this clinical trial is to learn if VENT-03 works to treat patients with cutaneous lupus erythematosus (CLE) …

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.